Name: Latest research reports of Jupiter Life Line Hospitals Ltd. authored by Anand Rathi and published by - Trendlyne research reports.
Item: Jupiter Life Line Hospitals Ltd.
Rating: 5
Author: Anand Rathi

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	12 Nov 2024	Jupiter Life Line	Anand Rathi	1423.90	1740.00	1542.20 (-7.67%)	Target met	Buy	pdf post cache	Broker Report Healthy show across units; maintaining a Buy Anand Rathi In line with our estimates and consensus, Jupiter Lifeline Hospital reported healthy Q2 figures, with revenue/EBITDA/PAT up23%/23%/53% y/y. pdf Copy Link Share on Share on Share on Share on Alert
	12 Nov 2024	Hindalco Industries	Anand Rathi	651.15	800.00	651.65 (-0.08%)	22.86	Buy	pdf post cache	Broker Report Best-in-class upstream aluminium margin, record copper EBITDA; Buy Anand Rathi Hindalco Industries’ strategic expansion in Bay Minette is on track and the recently commissioned 250k tonne Guthrie facility is ramping up, with production having commenced in Q2. pdf Copy Link Share on Share on Share on Share on Alert
	12 Nov 2024	Shree Cements	Anand Rathi	30210.00	28600.00	24372.80 (23.95%)	Target met	Buy	pdf post cache	Broker Report Weak Q2, capacity targeted at 80m tonnes by FY28; retaining a Buy Anand Rathi Shree Cements’ Q2 was muted due to the weak demand-pricing environment, owing to prolonged monsoons and low infrastructure spends by the government. pdf Copy Link Share on Share on Share on Share on Alert
	10 Nov 2024	Emami	Anand Rathi	635.00	900.00	669.85 (-5.20%)	41.73	Buy	pdf post cache	Broker Report Q2 dragged by TMC transition, Bangladesh, but H2 outlook bright; Buy Anand Rathi With Rs8.9bn revenue (vs. the Street’s Rs9.1bn estimate) and EBITDA atRs2.5bn (Rs2.5bn), Emami’s Q2 was broadly in line with estimates. pdf Copy Link Share on Share on Share on Share on Alert
	10 Nov 2024	MRF	Anand Rathi	139970.00	160000.00	119354.30 (17.27%)	14.31	Buy	pdf post cache	Broker Report Margins to expand ahead, upgrading to a Buy Anand Rathi Broadly in line with our Rs9.7bn estimate, MRF’s Q2 EBITDA fell 14% y/y to Rs9.7bn. pdf Copy Link Share on Share on Share on Share on Alert
	10 Nov 2024	Greenlam Industries	Anand Rathi	223.00	801.00	555.85 (-59.88%)	Pre-Bonus/ Split	Buy	pdf post cache	Broker Report Good performance, eyes on plywood, particle boards; retaining a Buy Anand Rathi Greenlam’s Q2 revenue climbed 12.8% y/y to Rs6.8bn. The 52% gross margin was broadly the same. EBITDA rose 7.7% y/y to Rs 814m, while PAT was significantly down 11.6% y/y to Rs 345m. pdf Copy Link Share on Share on Share on Share on Alert
	07 Nov 2024	Greenply Industries	Anand Rathi Reco Target	281.40	375.00	361.15 (-22.08%)	33.26	Hold	pdf post cache	Broker Report Decent operational performance, one-offs impact PAT; reducing to a Hold Anand Rathi Greenply’s revenue/gross profit/EBITDA grew 12.8/12.3/19.2% y/y to Rs6.4bn/2.5bn/576m, though adj. PAT was 6.1% lower y/y at Rs176m. pdf Copy Link Share on Share on Share on Share on Alert
	07 Nov 2024	Page Industries	Anand Rathi	47025.00	48947.00	45064.10 (4.35%)	Target met	Hold	pdf post cache	Broker Report Better-than-expected performance; retaining a Hold Anand Rathi Page’s Q2 figures exceeded our estimates and consensus. The q/q better demand was aided by festivals at quarter-end, and a gradual rural recovery. pdf Copy Link Share on Share on Share on Share on Alert
	07 Nov 2024	Amara Raja Energy	Anand Rathi Reco Target	1000.45	1490.00	1311.25 (-23.70%)	48.93	Hold	pdf post cache	Broker Report Greater potential; upgrading to a Hold Anand Rathi Belieing our Rs5bn estimate, Amara Raja’s Q2 standalone EBITDA grew 14% y/y to Rs4.4bn due to the lower-than-expected gross margin. pdf Copy Link Share on Share on Share on Share on Alert
	06 Nov 2024	Oil	Anand Rathi	415.90	644.00	525.10 (-20.80%)	54.84	Buy	pdf post cache	Broker Report Risk-reward favourable; upgrading to a Buy Anand Rathi Less downstream demand due to a maintenance shutdown kept Oil India’s Q2 operational results muted. Ahead, we expect strong volume growth in the oil & gas segment. pdf Copy Link Share on Share on Share on Share on Alert
more loading

Anand Rathi Broker Research reports

Latest broker research reports from Anand Rathi buy, sell, hold, neutral recommendations along with share price targets forecast and upside.

Healthy show across units; maintaining a Buy

Best-in-class upstream aluminium margin, record copper EBITDA; Buy

Weak Q2, capacity targeted at 80m tonnes by FY28; retaining a Buy

Q2 dragged by TMC transition, Bangladesh, but H2 outlook bright; Buy

Margins to expand ahead, upgrading to a Buy

Good performance, eyes on plywood, particle boards; retaining a Buy

Decent operational performance, one-offs impact PAT; reducing to a Hold

Better-than-expected performance; retaining a Hold

Greater potential; upgrading to a Hold

Risk-reward favourable; upgrading to a Buy

Advisor Screeners